Herriot Tabuteau, Chief Executive Officer, 10% Owner at Axsome Therapeutics, Inc. (AXSM), sold 139,414 shares at $171.28 ($23.9M) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $23.9M AXSM by Chief Executive Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $171.28 | 78,703 | $13.5M | 56.4% |
| 2 | $172.33 | 29,450 | $5.1M | 21.3% |
| 3 | $170.38 | 31,261 | $5.3M | 22.3% |
| Total | $171.30 avg | 139,414 | $23.9M | 100% |
| Filing → |
| AXSM | SELL | 2026-06-09 | $12.0M | — | Filing → |
| AXSM | SELL | 2026-02-02 | $6.0M | — | Filing → |
| AXSM | SELL | 2025-12-04 | $23.3M | — | Filing → |